Serotonin-2C receptors in the basolateral nucleus of the amygdala mediate the anxiogenic effect of acute imipramine and fluoxetine administration


Autoria(s): Vicente, Maria Adrielle; Zangrossi Junior, Helio
Contribuinte(s)

UNIVERSIDADE DE SÃO PAULO

Data(s)

06/11/2013

06/11/2013

2012

Resumo

A growing body of evidence indicates that facilitation of serotonin-2C receptor (5-HT2CR)-mediated neurotransmission in the basolateral nucleus of the amygdala (BLA) is involved in anxiety generation. We investigated here whether BLA 5-HT(2C)Rs exert a differential role in the regulation of defensive behaviours related to generalized anxiety (inhibitory avoidance) and panic (escape) disorders. We also evaluated whether activation of BLA 5-HT(2C)Rs accounts for the anxiogenic effect caused by acute systemic administration of the antidepressants imipramine and fluoxetine. Male Wistar rats were tested in the elevated T-maze after intra-BLA injection of the endogenous agonist 5-HT, the 5-HT2CR agonist MK-212 or the 5-HT2CR antagonist SB-242084. This test allows the measurement of inhibitory avoidance acquisition and escape expression. We also investigated whether intra-BLA administration of SB-242084 interferes with the acute anxiogenic effect caused by imipramine and fluoxetine in the Vogel conflict test, and imipramine in the elevated T-maze. While intra-BLA administration of 5-HT and MK-212 facilitated inhibitory avoidance acquisition, suggesting an anxiogenic effect, SB-242084 had the opposite effect. None of these drugs affected escape performance. Intra-BLA injection of a sub-effective dose of SB-242084 fully blocked the anxiogenic effect caused either by the local microinjection of 5-HT or the systemic administration of imipramine and fluoxetine. Our findings indicate that 5-HT(2C)Rs in BLA are selectively involved in the regulation of defensive behaviours associated with generalized anxiety, but not panic. The results also provide the first direct evidence that activation of BLA 5-HT(2C)Rs accounts for the short-term aversive effect of antidepressants.

FAPESP

CNPq (Brazil)

Identificador

INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, NEW YORK, v. 15, n. 3, pp. 389-400, APR, 2012

1461-1457

http://www.producao.usp.br/handle/BDPI/42414

10.1017/S1461145711000873

http://dx.doi.org/10.1017/S1461145711000873

Idioma(s)

eng

Publicador

CAMBRIDGE UNIV PRESS

NEW YORK

Relação

INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Direitos

closedAccess

Copyright CAMBRIDGE UNIV PRESS

Palavras-Chave #ANTIDEPRESSANT #ANXIETY #BASOLATERAL AMYGDALA #SEROTONIN #ELEVATED T-MAZE #DORSAL PERIAQUEDUCTAL GRAY #ANXIETY-LIKE BEHAVIOR #5-HT2C RECEPTOR #REUPTAKE INHIBITORS #PLUS-MAZE #ANXIOUS STATES #ANIMAL-MODELS #DOUBLE-BLIND #IN-VIVO #CLINICAL NEUROLOGY #NEUROSCIENCES #PHARMACOLOGY & PHARMACY #PSYCHIATRY
Tipo

article

original article

publishedVersion